Ibrutinib facilitates the sensitivity of colorectal cancer cells to ferroptosis through BTK/NRF2 pathway

Ibrutinib is a drug that inhibits the protein Burton’s tyrosine kinase and thereby the nuclear translocation of Nrf2, which played a key role in mediating the activation of antioxidants during stress conditions and ferroptosis resistance. This study aimed to identify the effect of Ibrutinib and ferr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jin-Feng, Liu, Yi, Li, Wen-Ting, Li, Ming-Hui, Zhen, Chao-Hui, Sun, Pei-Wei, Chen, Ji-Xin, Wu, Wen-Hao, Zeng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950074/
https://www.ncbi.nlm.nih.gov/pubmed/36823108
http://dx.doi.org/10.1038/s41419-023-05664-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950074/
https://www.ncbi.nlm.nih.gov/pubmed/36823108
http://dx.doi.org/10.1038/s41419-023-05664-9

Ejemplares similares